| Jeffrey Ash, DPM | |
|
300 W Country Club Rd Ste 130, Roswell, NM 88201-5249 | |
| (575) 625-2669 | |
| (575) 625-1296 |
| Full Name | Jeffrey Ash |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 22 Years |
| Location | 300 W Country Club Rd Ste 130, Roswell, New Mexico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235149196 | NPI | - | NPPES |
| 4583990001 | Other | DMERC | |
| NPI & TIN | Other | NM | BCBS OF NM |
| 55155863 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 300 (New Mexico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Eastern New Mexico Medical Center | Roswell, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Roswell Clinic Corp | 9436062759 | 27 |
News Archive
"Gilead Sciences Inc. may learn this year whether its drugs for treating HIV can also stop people from catching the virus in the first place," Bloomberg writes in a piece that examines the potential benefits and drawbacks to using low-doses of HIV/AIDS medications to reduce a person's risk of becoming infected with HIV. According to the news service, the initial results of 10 trials including more than 20,000 people could be available as early as July.
Researchers at Oregon Health & Science University have discovered that brain cells commonly thought to play a supporting role actually are critically important for the growth of brainstem neurons responsible for cardiorespiratory control. The discovery has profound implications for the prevention and treatment of SIDS (Sudden Infant Death Syndrome), the leading cause of death in children aged one month to one year.
Johnson & Johnson and Micrus Endovascular Corporation, a global developer and manufacturer of minimally invasive devices to address hemorrhagic and ischemic stroke, today announced a definitive agreement whereby Micrus Endovascular will be acquired in a cash for stock exchange.
Organ transplant patients routinely receive drugs that stop their immune systems from attacking newly implanted hearts, livers, kidneys or lungs, which the body sees as foreign.
› Verified 2 days ago
| Provider Name | Roswell Clinic Corp |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1649267618 PECOS PAC ID: 9436062759 Enrollment ID: O20031111000799 |
News Archive
"Gilead Sciences Inc. may learn this year whether its drugs for treating HIV can also stop people from catching the virus in the first place," Bloomberg writes in a piece that examines the potential benefits and drawbacks to using low-doses of HIV/AIDS medications to reduce a person's risk of becoming infected with HIV. According to the news service, the initial results of 10 trials including more than 20,000 people could be available as early as July.
Researchers at Oregon Health & Science University have discovered that brain cells commonly thought to play a supporting role actually are critically important for the growth of brainstem neurons responsible for cardiorespiratory control. The discovery has profound implications for the prevention and treatment of SIDS (Sudden Infant Death Syndrome), the leading cause of death in children aged one month to one year.
Johnson & Johnson and Micrus Endovascular Corporation, a global developer and manufacturer of minimally invasive devices to address hemorrhagic and ischemic stroke, today announced a definitive agreement whereby Micrus Endovascular will be acquired in a cash for stock exchange.
Organ transplant patients routinely receive drugs that stop their immune systems from attacking newly implanted hearts, livers, kidneys or lungs, which the body sees as foreign.
› Verified 2 days ago
| Provider Name | Masoud Khorsand-sahbaie Md Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1932187044 PECOS PAC ID: 8729068911 Enrollment ID: O20040720000920 |
News Archive
"Gilead Sciences Inc. may learn this year whether its drugs for treating HIV can also stop people from catching the virus in the first place," Bloomberg writes in a piece that examines the potential benefits and drawbacks to using low-doses of HIV/AIDS medications to reduce a person's risk of becoming infected with HIV. According to the news service, the initial results of 10 trials including more than 20,000 people could be available as early as July.
Researchers at Oregon Health & Science University have discovered that brain cells commonly thought to play a supporting role actually are critically important for the growth of brainstem neurons responsible for cardiorespiratory control. The discovery has profound implications for the prevention and treatment of SIDS (Sudden Infant Death Syndrome), the leading cause of death in children aged one month to one year.
Johnson & Johnson and Micrus Endovascular Corporation, a global developer and manufacturer of minimally invasive devices to address hemorrhagic and ischemic stroke, today announced a definitive agreement whereby Micrus Endovascular will be acquired in a cash for stock exchange.
Organ transplant patients routinely receive drugs that stop their immune systems from attacking newly implanted hearts, livers, kidneys or lungs, which the body sees as foreign.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Ash, DPM 300 W Country Club Rd Ste 130, Roswell, NM 88201-5249 Ph: (575) 625-2669 | Jeffrey Ash, DPM 300 W Country Club Rd Ste 130, Roswell, NM 88201-5249 Ph: (575) 625-2669 |
News Archive
"Gilead Sciences Inc. may learn this year whether its drugs for treating HIV can also stop people from catching the virus in the first place," Bloomberg writes in a piece that examines the potential benefits and drawbacks to using low-doses of HIV/AIDS medications to reduce a person's risk of becoming infected with HIV. According to the news service, the initial results of 10 trials including more than 20,000 people could be available as early as July.
Researchers at Oregon Health & Science University have discovered that brain cells commonly thought to play a supporting role actually are critically important for the growth of brainstem neurons responsible for cardiorespiratory control. The discovery has profound implications for the prevention and treatment of SIDS (Sudden Infant Death Syndrome), the leading cause of death in children aged one month to one year.
Johnson & Johnson and Micrus Endovascular Corporation, a global developer and manufacturer of minimally invasive devices to address hemorrhagic and ischemic stroke, today announced a definitive agreement whereby Micrus Endovascular will be acquired in a cash for stock exchange.
Organ transplant patients routinely receive drugs that stop their immune systems from attacking newly implanted hearts, livers, kidneys or lungs, which the body sees as foreign.
› Verified 2 days ago
Mark D Antenucci Dpm Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 313 W Country Club Rd, Suite 7, Roswell, NM 88201 Phone: 575-624-2398 Fax: 575-624-0655 | |
Dr. Mark David Antenucci, D.P.M Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 313 West Country Club Rd., Ste. 7, Roswell, NM 88201 Phone: 575-624-2398 Fax: 575-624-0655 |